Resumo

QUEVEDO, Germán  e  TERAN, Aracelly. Endoscopic treatment with deflux in vesicoureteral reflux. Rev. bol. ped. [online]. 2009, vol.48, n.1, pp.7-11. ISSN 1024-0675.

Background: the treatment of vesicoureteral reflux (VUR) has gone through several stages, from the clinic to the surgical management. The implementation of endoscopic substances at the ureteral meatus which was successful in other centers, prompted us to introduce this treatment in search of a safe and less invasive alternative to the resolution of VUR. Purpose: this study reviewed the results achieved with the implementation of Delux (copolymer of dextranomer in hyaluronic acid) in patients with varying degrees of VUR. At the Japanese University Hospital of Santa Cruz de la Sierra. Method: we studied to 7 patients with VUR with unique systems, with a total of 13 ureters with VUR grade I to IV, affecting 53% and 47% left-right side respectively, in which Delux was injected in the period September 2007 through April 2008. We urinary tract control through ultrasound within thirty days and voiding cistourethrography control within three months after the injection. Results: 71% of patients were females, aged 1 year 5 months to 5 years and 6 months with an average of 2 years 6 months. The disposition of cases was 85% with an application and 90% with two applications. Grades I and II had a resolution of 100% with one application. A greater degree of VUR, the lower the percentage of resolution and greater need for a second application. All patients underwent surgery in outpatient placement with a mean of 5 hours. Conclusions: the use of Deflux is an excellent alternative for treating Vesicoureteral relux.

Palavras-chave : vesicoureteral relux; endoscopic treatment; Delux.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )